EG 427
Industry · 2 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Long-term Follow-up Study of Patients Who Received EG110A, a Non-replicative Herpes Simplex Virus 1-derived Ge Urinary Bladder, Overactive, Spinal Cord Injury | Phase 1 / Phase 2 | 2026-04-01 |
| Recruiting | Dose Escalation Study of EG110A, Administered by Intradetrusor Injections to Adults With Neurogenic Detrusor O Neurogenic Detrusor Overactivity, Spinal Cord Injuries | Phase 1 / Phase 2 | 2025-01-08 |